ADPT

Adaptive Biotechnologies Corporation

3.51 USD
-0.14 (-3.84%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Adaptive Biotechnologies Corporation stock is up 27.64% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 May’s closed higher than April.

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals. It serves the life sciences research, clinical diagnostics, and drug discovery applications.